Luckys Pharma Lab Private Limited

Product Introduction

Razin LS Capsule is a prescription medication used in the treatment of gastroesophageal reflux disease (acid reflux), intestinal ulcers, and irritable bowel syndrome. It works by reducing excess acid production in the stomach and preventing the reflux of stomach acid into the food pipe.

Key Features

• Reduces excess acid production in the stomach
• Prevents reflux of stomach acid into the food pipe
• Suitable for long-term use under doctor's supervision

Noteas 250 Tablet Overview:

Noteas 250 Tablet is a combination medication prescribed for the prevention of migraines. It contains two active ingredients that work together to alleviate migraine symptoms by blocking the release of certain chemical messengers responsible for pain, inflammation, nausea, and vomiting associated with migraines.

Administration:

• Noteas 250 Tablet may be prescribed as a standalone treatment or in combination with other medications, as determined by your healthcare provider.
• It can be taken with or without food, as per your doctor's instructions.
• The dosage and duration of treatment will vary based on the severity of your condition and your response to the medication. It's important to adhere to the prescribed regimen and not discontinue its use without consulting your doctor.

Introduction

Depagin M 10/1000mg Tablet is a combination medication used in the management of type 2 diabetes mellitus. It aids in controlling elevated blood sugar levels associated with diabetes, thereby reducing the risk of serious complications and preventing heart disease.

Uses

Depagin M 10/1000mg Tablet is indicated for the treatment of type 2 diabetes mellitus.

Benefits

Depagin M 10/1000mg Tablet helps regulate high blood glucose levels by facilitating the removal of excess glucose from the body through urine. Lowering blood glucose levels is crucial for managing diabetes and reducing the risk of associated complications such as kidney damage, eye damage, nerve problems, and limb loss. Additionally, this medication reduces the risk of cardiovascular disease-related mortality in individuals with type 2 diabetes who already have cardiovascular disease. When taken regularly along with a proper diet and exercise regimen, it supports a normal, healthy life. Continuation of treatment as prescribed is essential for safeguarding future health.

Glimiford, marketed by Luckys Pharma Lab Pvt. Ltd., is a clinically trusted oral anti-diabetic formulation that combines Glimepiride and Metformin Hydrochloride to provide effective glycemic control in patients with Type 2 Diabetes Mellitus. Glimepiride, a sulfonylurea, works by stimulating insulin secretion from the pancreas, while Metformin, a biguanide, reduces hepatic glucose production and enhances peripheral insulin sensitivity. This dual-action therapy addresses both insulin deficiency and resistance, helping manage both fasting and postprandial blood glucose levels. Glimiford is well-tolerated, does not cause significant weight gain, and offers a convenient and cost-effective solution for long-term diabetes management. It is available in multiple strengths to suit individual patient needs, and is backed by the trusted quality and commitment of Luckys Pharma Lab Pvt. Ltd.

Key Features

• Dual-action formula for comprehensive symptom relief in asthma and COPD.
• Precision-engineered rotacap design for convenient and accurate dosing.
• Long-lasting efficacy with gradual onset of action for sustained therapeutic benefit.
• Suitable for long-term use, promoting symptom control and improved lung function.
• Emphasizes the importance of correct inhaler technique for enhanced drug efficacy.

INTRODUCTION OF lEVOICE A2

Levoice - A2 Tablet is used to treat and prevent asthma and symptoms of chronic obstructive pulmonary disorder such as coughing, wheezing and shortness of breath. It helps relax the muscles of the air passage thereby making it easier to breathe.

Levoice - A2 tablet is taken with or without food in a dose and duration as advised by the doctor. The dose you are given will depend on your condition and how you respond to the medicines. You should keep taking these medicines for as long as your doctor 

recommends. If you stop treatment too early your symptoms may come back and your conditions may worsen.

USES

 Treatment of chronic obstructive pulmonary disease (copd)

 
BENEFITS

 Levoice - A2 tablet is a combination of two medicines that helps the airways in your lungs stay open. They work by relaxing the muscles of their airways. This makes it easier of air to get in and out. This medicines also loosens thick mucus, making it easier to cough out. It will relieve symptoms such as tightness in your chest, shortness of breath, wheezing and coughing and help you carry out your daily activities more easily. This medicine is safe and effective. It usually starts to work within few minutes and the effects can last up to several hours. Take it as prescribed by the doctor. Do not stop using it unless you are advised to by your doctor.

Lace SP Tablet is a combination medication that includes Aceclofenac (an NSAID), Paracetamol (an analgesic and antipyretic), and Serratiopeptidase (an anti-inflammatory enzyme). This combination is used to relieve pain, reduce inflammation, and improve healing in various conditions, particularly those involving musculoskeletal pain and inflammation.

• Aceclofenac: Inhibits the enzyme cyclooxygenase (COX), reducing the synthesis of prostaglandins which are mediators of pain and inflammation.
• Paracetamol: Acts centrally in the brain to provide pain relief and reduce fever. It inhibits prostaglandin synthesis in the central nervous system and blocks pain impulse generation.
• Serratiopeptidase: An enzyme that breaks down proteins involved in inflammation, reducing swelling and facilitating faster healing of inflamed tissues.

Lace SP Tablet is indicated for the treatment of:

• Osteoarthritis
• Rheumatoid arthritis
• Ankylosing spondylitis
• Musculoskeletal pain
• Postoperative pain and inflammation
• Dental pain
• Other inflammatory conditions

• Dosage: The typical adult dose is one tablet taken twice daily. The dosage may be adjusted based on the severity of the condition and the patient’s response to the medication.
• Administration: Take orally with a glass of water. It can be taken with or after food to minimize gastrointestinal irritation.

Razin LS combines Rabeprazole Sodium (EC) 20 mg and Levosulpiride (SR) 75 mg in a single formulation. Rabeprazole is a proton pump inhibitor (PPI) that helps to reduce stomach acid production, making it effective in treating conditions like gastroesophageal reflux disease (GERD), peptic ulcers, and dyspepsia. It works by blocking the enzyme responsible for acid secretion in the stomach, thereby providing relief from acid-related symptoms.

Levosulpiride, on the other hand, is a prokinetic agent that enhances gastrointestinal motility. It helps to regulate the movement of food through the digestive system and can be particularly beneficial in treating functional dyspepsia and other motility disorders. Levosulpiride also has some antidepressant properties and is used to alleviate symptoms such as bloating, nausea, and discomfort associated with gastrointestinal disorders.

Together, the combination of Rabeprazole and Levosulpiride in Razin LS offers dual benefits by addressing both the underlying cause of acid-related disorders and improving gastrointestinal motility, thereby providing comprehensive relief from digestive discomfort and associated symptoms. It is important to use Razin LS as prescribed by a healthcare professional to optimize its therapeutic benefits and minimize potential side effects.

Razin LS combines Rabeprazole Sodium (EC) 20 mg and Levosulpiride (SR) 75 mg in a single formulation. Rabeprazole is a proton pump inhibitor (PPI) that helps to reduce stomach acid production, making it effective in treating conditions like gastroesophageal reflux disease (GERD), peptic ulcers, and dyspepsia. It works by blocking the enzyme responsible for acid secretion in the stomach, thereby providing relief from acid-related symptoms.

Levosulpiride, on the other hand, is a prokinetic agent that enhances gastrointestinal motility. It helps to regulate the movement of food through the digestive system and can be particularly beneficial in treating functional dyspepsia and other motility disorders. Levosulpiride also has some antidepressant properties and is used to alleviate symptoms such as bloating, nausea, and discomfort associated with gastrointestinal disorders.

Together, the combination of Rabeprazole and Levosulpiride in Razin LS offers dual benefits by addressing both the underlying cause of acid-related disorders and improving gastrointestinal motility, thereby providing comprehensive relief from digestive discomfort and associated symptoms. It is important to use Razin LS as prescribed by a healthcare professional to optimize its therapeutic benefits and minimize potential side effects.

Tropium is a respirator solution containing ipratropium bromide, an anticholinergic bronchodilator designed for the management of chronic obstructive pulmonary disease (COPD) and asthma. Ipratropium bromide works by blocking the action of acetylcholine, a neurotransmitter that causes the muscles around the airways to contract. By inhibiting this action, Tropium helps to relax and widen the airways, making it easier to breathe and providing relief from symptoms such as wheezing, shortness of breath, and chest tightness.

Administered via a nebulizer, Tropium is particularly beneficial for patients who may have difficulty using standard inhalers, including young children and the elderly. The nebulizer converts the solution into a fine mist, ensuring that the medication is delivered directly to the lungs for effective and rapid bronchodilation.

Tropium is typically used as part of a regular treatment regimen to manage chronic respiratory conditions, improving lung function and enhancing the quality of life for patients with COPD and asthma. Common side effects may include dry mouth, cough, and throat irritation, while serious side effects are rare but can include urinary retention and worsening of narrow-angle glaucoma.

Forbude 0.5 is a respirator suspension that combines formoterol fumarate and budesonide, offering an advanced therapeutic solution for managing asthma and chronic obstructive pulmonary disease (COPD). Formoterol fumarate, a long-acting beta-agonist (LABA), works by relaxing the muscles around the airways, providing extended bronchodilation and helping to prevent symptoms such as wheezing, shortness of breath, and chest tightness. Budesonide, a corticosteroid, effectively reduces inflammation within the airways, decreasing swelling and mucus production, which contributes to long-term control and prevention of asthma attacks and COPD exacerbations.

The combination of these two active ingredients in Forbude 0.5 ensures both immediate and sustained relief from respiratory symptoms. Formoterol offers fast-acting bronchodilation that lasts for up to 12 hours, while budesonide's anti-inflammatory properties address the underlying inflammation, providing comprehensive management of chronic respiratory conditions. This dual-action approach enhances overall lung function, reduces the frequency of exacerbations, and improves the quality of life for patients.

BUDEFLO 200: Dual Therapy for Effective Respiratory Management

BUDEFLO 200 combines Budesonide I.P. 200 mcg and Formoterol Fumarate Dihydrate I.P. 6 mcg, offering a powerful dual-action approach to manage asthma and chronic obstructive pulmonary disease (COPD). Budesonide, a potent inhaled corticosteroid (ICS), reduces airway inflammation, prevents swelling, and minimizes the risk of exacerbations. Formoterol Fumarate, a long-acting beta-agonist (LABA), ensures rapid and sustained bronchodilation, providing quick relief from breathing difficulties and improving airflow.

Budecide 1 mg is a nebulizer suspension containing budesonide, a potent corticosteroid used for the treatment and management of chronic respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD). Budesonide works by reducing inflammation in the airways, leading to decreased swelling and mucus production, which helps to prevent asthma attacks and control COPD symptoms. By targeting the underlying inflammation that contributes to breathing difficulties, Budecide 1 mg provides long-term relief and improves overall lung function.

Administered via a nebulizer, Budecide 1 mg delivers the medication directly to the lungs in the form of a fine mist. This method ensures efficient absorption of budesonide at the site of action, providing effective symptom relief and control. The nebulizer is particularly beneficial for patients who may have difficulty using traditional inhalers, including young children and the elderly.

Budecide 1 mg is typically used as part of a regular treatment regimen to manage chronic respiratory conditions. Regular use of this medication helps improve overall lung function, reduces the frequency and severity of asthma attacks, and minimizes COPD exacerbations. By addressing the root cause of inflammation in the airways, Budecide 1 mg helps patients maintain better respiratory health and enhances their quality of life.

BUDEFLO 400 Keyhaler: Advanced Dual Therapy for Severe Respiratory Conditions

BUDEFLO 400 Keyhaler is a powerful combination of Budesonide I.P. 400 mcg and Formoterol Fumarate Dihydrate I.P. 6 mcg, specifically designed for the effective management of asthma and severe chronic obstructive pulmonary disease (COPD). Budesonide, a high-dose inhaled corticosteroid (ICS), reduces airway inflammation, prevents swelling, and lowers the risk of exacerbations. Formoterol Fumarate, a long-acting beta-agonist (LABA), delivers rapid and sustained bronchodilation, ensuring quick relief from bronchospasms and improved airflow.